M. Wilsey
Chairman bei SAREPTA THERAPEUTICS, INC.
Vermögen: 29 Mio $ am 31.03.2024
Profil
Dr. M. K. Wilsey ist Chairman bei MiMedx Group, Inc. und unabhängiges Mitglied des Verwaltungsrats bei IGM Biosciences, Inc. und Chairman bei Sarepta Therapeutics, Inc. Sie ist Mitglied des Board of Directors von IGM Biosciences, Inc. Dr. Wilsey war zuvor als unabhängiger Director bei Amylin Pharmaceuticals, Inc. beschäftigt, als President & Chief Executive Officer bei KEW Group, Inc. ein Mitglied des President's Council of Advisors on Science & Technology, ein Director-Science, Technology & Economic Policy bei The National Research Council, ein Managing Director bei RS Investment Management Co. LLC, Vorsitzende & Präsidentin der National Venture Capital Association, Geschäftsführerin & General Partner von Robertson Stephens & Co. und Mitbegründerin der Coalition for 21st Century Medicine. Sie war auch im Vorstand von Abgenix, Inc. Sie erhielt ihren Bachelor-Abschluss von der University of California, Davis und einen Doktortitel von der University of California, Davis.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 01.03.2024 | 186 839 ( 0,20% ) | 24 Mio $ | 31.03.2024 | |
IGM BIOSCIENCES, INC.
1,20% | 29.03.2024 | 400 359 ( 1,20% ) | 4 Mio $ | 31.03.2024 |
MIMEDX GROUP, INC.
0,11% | 13.06.2023 | 160 972 ( 0,11% ) | 1 Mio $ | 31.03.2024 |
Aktive Positionen von M. Wilsey
| Unternehmen | Position | Beginn |
|---|---|---|
| SAREPTA THERAPEUTICS, INC. | Chairman | 16.04.2015 |
| IGM BIOSCIENCES, INC. | Director/Board Member | 31.01.2019 |
| MIMEDX GROUP, INC. | Chairman | 19.06.2019 |
Ehemalige bekannte Positionen von M. Wilsey
| Unternehmen | Position | Ende |
|---|---|---|
Kew, Inc.
 Kew, Inc. Medical/Nursing ServicesHealth Services Kew, Inc. provides oncology services. It provides multiple services to oncologists to assist in treatment decisions for cancer patients and offers genomic testing for patient tumor samples and genomic information important to diagnostic and treatment decisions that assist physicians and are detailed in cancer-specific Therapeutic Pathways. The company was founded by Richard Bohmer, Viren Mehta, Clayton Matt Christensen, Jeffrey Elton, Mason Freeman, John P. Glaser, H. Robert Horvitz, Bruce Johnson, Kathy Behrens Wilsey and Raju S. Kucherlapat in 2009 and is headquartered in Cambridge, MA. | Chief Executive Officer | - |
Amylin Pharmaceuticals, Inc.
 Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amylin Pharmaceuticals, Inc. develops and commercializes medicines for diabetes, obesity, and cardiovascular diseases. The company was founded on September 29, 1987 by Howard E. Greene, Jr. and is headquartered in San Diego, CA. | Director/Board Member | 08.08.2012 |
RS Investment Management Co. LLC
 RS Investment Management Co. LLC Investment ManagersFinance RS Investment Management Co. LLC (also known as RS Investments) is an investment advisor and mutual fund manager headquartered in San Francisco, California. Founded in 1986, the firm was acquired by Victory Capital Management, Inc. from The Guardian Life Insurance Co. of America in July 2016. They operate as an independent franchise within Victory Capital's multi-boutique model. Each of the teams within the RS franchise continues to operate autonomously. RS Investments provides investment advisory services to mutual funds, institutions, private pooled investment vehicles, and high net-worth individuals. | Corporate Officer/Principal | 01.12.2009 |
| President's Council of Advisors on Science & Technology | Corporate Officer/Principal | 01.01.2009 |
Abgenix, Inc.
 Abgenix, Inc. BiotechnologyHealth Technology Abgenix, Inc. developed therapeutic products. It focused on the discovery, development and manufacturing of therapeutic antibodies. The firm's antibody development platform included manufacturing fully human antibody product candidates to a variety of disease targets. The company was founded by R. Scott Greer in 1996 and was headquartered in Fremont, CA. | Director/Board Member | - |
Ausbildung von M. Wilsey
| University of California, Davis | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| SAREPTA THERAPEUTICS, INC. | Health Technology |
| IGM BIOSCIENCES, INC. | Health Technology |
| MIMEDX GROUP, INC. | Health Technology |
| Private Unternehmen | 9 |
|---|---|
Amylin Pharmaceuticals, Inc.
Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amylin Pharmaceuticals, Inc. develops and commercializes medicines for diabetes, obesity, and cardiovascular diseases. The company was founded on September 29, 1987 by Howard E. Greene, Jr. and is headquartered in San Diego, CA. | Health Technology |
Abgenix, Inc.
Abgenix, Inc. BiotechnologyHealth Technology Abgenix, Inc. developed therapeutic products. It focused on the discovery, development and manufacturing of therapeutic antibodies. The firm's antibody development platform included manufacturing fully human antibody product candidates to a variety of disease targets. The company was founded by R. Scott Greer in 1996 and was headquartered in Fremont, CA. | Health Technology |
RS Investment Management Co. LLC
RS Investment Management Co. LLC Investment ManagersFinance RS Investment Management Co. LLC (also known as RS Investments) is an investment advisor and mutual fund manager headquartered in San Francisco, California. Founded in 1986, the firm was acquired by Victory Capital Management, Inc. from The Guardian Life Insurance Co. of America in July 2016. They operate as an independent franchise within Victory Capital's multi-boutique model. Each of the teams within the RS franchise continues to operate autonomously. RS Investments provides investment advisory services to mutual funds, institutions, private pooled investment vehicles, and high net-worth individuals. | Finance |
| Robertson Stephens & Co. | Finance |
National Venture Capital Association
 National Venture Capital Association Miscellaneous Commercial ServicesCommercial Services National Venture Capital Association provides business association services. It facilitates networking opportunities and provides research data to its members. The company is headquartered in Washington, DC. | Commercial Services |
| President's Council of Advisors on Science & Technology | Government |
The National Research Council
 The National Research Council Miscellaneous Commercial ServicesCommercial Services The National Research Council provides science, technology and health policy consulting and advice. The company was founded in 1916 and is headquartered in Washington, DC. | Commercial Services |
Kew, Inc.
Kew, Inc. Medical/Nursing ServicesHealth Services Kew, Inc. provides oncology services. It provides multiple services to oncologists to assist in treatment decisions for cancer patients and offers genomic testing for patient tumor samples and genomic information important to diagnostic and treatment decisions that assist physicians and are detailed in cancer-specific Therapeutic Pathways. The company was founded by Richard Bohmer, Viren Mehta, Clayton Matt Christensen, Jeffrey Elton, Mason Freeman, John P. Glaser, H. Robert Horvitz, Bruce Johnson, Kathy Behrens Wilsey and Raju S. Kucherlapat in 2009 and is headquartered in Cambridge, MA. | Health Services |
| The Coalition for 21st Century Medicine |
